GlassScriptPhysician profile
Nancy G Johnson
NPI 1023007341
$1,557.39
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $451 · 2020: $315 · 2021: $401 · 2022: $199 · 2023: $172 · 2024: $18.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $173 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $172.70 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $248.70 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $201.07 | 2019-2021 | |
| Allergan, INC. | $190.93 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $173.06 | 2019-2023 | |
| Aerie Pharmaceuticals, INC. | $158.01 | 2019-2021 | |
| Quidel Corporation | $88.67 | 2020 | |
| Alcon Vision LLC | $84.26 | 2022-2024 | Simbrinza, Rocklatan |
| Bausch & Lomb Americas INC. | $62.33 | 2023 | Vyzulta, Miebo |
| New World Medical,INC. | $57.82 | 2022 | |
| Abbvie INC. | $56.42 | 2022 | |
| Biotissue Holdings INC. | $46.62 | 2019-2022 | |
| Thea Pharma INC. | $39.16 | 2023 | Iyuzeh |
| Johnson & Johnson Vision Care, INC. | $36.78 | 2019-2020 | |
| Sight Sciences, INC. | $34.35 | 2021-2022 | |
| Rxsight INC | $26.19 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Light Adjustable Lens (Rxlal) |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $19.73 | 2021 | |
| Shire North American Group INC | $18.60 | 2019 | |
| Kala Pharmaceuticals, INC. | $14.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.